Clinical trial
Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors
NCT00014378 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00014378 |
|---|---|
| Title | Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors |
| Official title | A Phase I Study Of The Chinese Herb Huanglian (Coptis Chinesis) In Patients With Advanced Solid Tumors |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | Chinese Herb Huanglian (Coptis chinesis) |
| Enrollment | 34 |
| Start date | Oct 1, 2000 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 18, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: